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Abstract 
Schwannomas are a kind of neurogenic tumor. They are generally benign and 
originate primarily from the central and peripheral nerve. They rarely develop in 
the gastrointestinal tract: gastric schwannomas make up 0.2% of gastric neoplasms. 
A malignant gastric schwannoma is a comparatively rare tumor, a few cases have 
been reported until now. We present the case of a 34-year-old male patient diagnosed 
during medical examination. The patient was treated with surgical resection, and 
2 years passed without recurrence. 
Introduction 
Schwannomas are rare among the spindle cell mesenchymal tumors of the digestive 
tract. They arise from Schwann cells of the neural plexus of the gastrointestinal wall [1]. 
Schwannomas make up approximately 0.2% of all gastric neoplasm. The tumors are 
usually benign, in some cases malignant [2]. Upper endoscopy is important in the 
evaluation on such tumors. However, on preoperative examination, it is difficult to Case Rep Gastroenterol 2011;5:502–507 
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discriminate a schwannoma from other submucosal tumors. Pathologically, in a 
schwannoma, immunostaining is positive for the S-100 protein and negative for c-KIT, 
actin, desmin, and CD34. The treatment is surgical resection. However, malignant cases 
often develop liver metastasis and peritoneal dissemination and have poor prognoses. 
Presented here is the case of a 34-year-old male with a schwannoma; after partial 
gastrectomy had been performed, there was no recurrence for 2 years. 
Case Report 
A 34-year-old male had an abnormal shadow detected in an examination of the upper 
gastrointestinal tract. He did not have any other clinical complaints and previous history. A barium 
meal showed an elevated lesion extended at the greater curvature of the gastric body. Gastrointestinal 
endoscopy showed an ulcerated submucosal mass at the greater curvature of the gastric body (fig. 1). 
The biopsy at the lesion was diagnosed as a submucosal tumor of spindle cell morphology such as a 
gastrointestinal stromal tumor (GIST), leiomyoma or neurogenic tumor. Computed tomography of the 
abdomen revealed a 2 cm mass at the greater curvature of the gastric body and splenomegaly. There was 
no evidence of metastasis or enlarged lymph nodes. As noted above, we diagnosed a submucosal tumor 
of the gastric body and performed a laparoscopy-assisted partial gastrectomy. The mass had elasticity, 
solidity and ulceration. There was no abnormality in the surrounding organs or lymph nodes. The 
tumor measured 19 × 18 mm (fig. 2). The patient had a complication-free postoperative course and was 
discharged 8 days following surgery. Immunohistochemically, the tumor was positive for the S-100 
protein and negative for c-KIT, CD34, desmin and actin. The tumor had spindle cell morphology and 
an active mitotic shape (fig. 3). It was pathologically diagnosed as a malignant gastric schwannoma. 
After discharge from the hospital, the patient was examined every 3 months by computed tomography 
or gastrointestinal endoscopy; there has been no recurrence for 2 years. 
Discussion 
Gastric schwannomas represent 0.2% of all gastric tumors [3, 4]. The patients are 
usually asymptomatic, and the tumors are detected during examinations. The patients 
may present with symptoms of abdominal pain or abdominal distension. Computed 
tomography, magnetic resonance imaging and gastrointestinal endoscopy are all useful in 
the diagnosis of gastric schwannomas. Computed tomography is helpful to define the 
exact location and extent of the tumor with displacement of surrounding organs. The 
schwannoma was visualized homogeneously and sharply marginated by computed 
tomography [5]. In magnetic resonance imaging, the overall signal pattern was low in 
T1-weighted images and moderate to markedly elevated in T2-weighted images [6]. 
Gastrointestinal endoscopy can be used to evaluate the size and location of a tumor. 
Typically, a schwannoma presents as a submucosal tumor. However, if a tumor presents 
ulceration, it is possible to achieve a pathological evaluation of the tumor by biopsy [7]. 
The pathological appearance is of whorled bundles of spindle-shaped cells with 
hyperchromatic nuclei (H&E stain). Immunohistochemically, positive staining for S-100 
protein and vimentin and negative staining for c-KIT, actin, desmin, and CD34 assist in 
the diagnosis of a schwannoma [8, 9]. Malignant schwannomas are very rare, and about 
20 cases have been reported in Japan [8]. In advanced cases, the tumor metastasizes to the 
liver and disseminates to the peritonea. However, the tumor does not metastasize to the 
lymph nodes. Surgical treatment is the exclusive method for treating a malignant 
schwannoma because chemotherapy and radiation are ineffective therapies [10]. Case Rep Gastroenterol 2011;5:502–507 
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With regard to small nonmetastatic schwannomas, it is difficult to determine the 
malignant potential of such tumors. FDG-PET is accepted as a powerful and noninvasive 
metabolic imaging modality for the evaluation of various tumors. Kamiyama et al. 
reported that FDG uptake and the malignant potential of gastric GISTs had a significant 
correlation [11]. However, in the case of schwannoma, benign tumors show higher FDG 
uptake [12]. Therefore, it is assumed that the evaluation of the malignant potential of a 
schwannoma by FDG uptake is inefficient. In this case the schwannoma was a 
nonmetastatic 2 cm in size; however, it has pathologically higher cell proliferation, 
abdominal mitosis, cellular atypia and invasion. Therefore, the potential of malignancy 
was pathologically indicated. The schwannoma in our case report was removed during a 
partial gastrectomy, and 2 years have passed without recurrence despite its pathologically 
malignant potential. The absence of recurrence is attributed to the size of the 
schwannoma. In fact, the size of the tumor may be linked to the potential for malignancy 
in GISTs. Local excision is necessary for the surgical removal of a schwannoma. 
Laparoscopy-assisted or laparoscopic resections are assumed to be suitable as minimally 
invasive surgical procedures. 
In conclusion we have reported a case of gastric schwannoma with pathologically 
malignant potential. In this case, 2 years have passed without recurrence since the 
laparoscopy-assisted resection. 
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Fig. 1. Endoscopy picture showing the ulcerated submucosal mass (arrow) at the greater curvature of 
the gastric body. 
 
 
 
Fig. 2. a Excised specimen of the tumor. b Coronal section of the tumor. 
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Fig. 3. a Hematoxylin-eosin staining (×200). b Immunohistochemical staining positive to S-100 
protein (×200). 
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